Stockscreener 앱 받기
45.60
2.77%
-1.30
전일 마감가:
$46.90
열려 있는:
$46.95
하루 거래량:
264.29K
Relative Volume:
0.53
시가총액:
$1.44B
수익:
$566.77M
순이익/손실:
$48.16M
주가수익비율:
38.32
EPS:
1.19
순현금흐름:
$274.29M
1주 성능:
+0.13%
1개월 성능:
-6.38%
6개월 성능:
+43.53%
1년 성능:
+36.28%
1일 변동 폭
$45.52
$47.16
1주일 범위
$45.00
$48.43
52주 변동 폭
$23.23
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
45.60 | 1.48B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
124.65 | 55.21B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.16 | 51.59B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 43.51B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.76 | 37.11B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
464.93 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-01-10 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-05-10 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-10 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-25 | 재확인 | Needham | Buy |
| 2023-05-02 | 재개 | Jefferies | Buy |
| 2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-14 | 개시 | BWS Financial | Sell |
| 2020-05-27 | 개시 | Guggenheim | Neutral |
| 2020-02-19 | 재개 | Jefferies | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-03 | 재개 | H.C. Wainwright | Buy |
| 2019-04-12 | 재개 | Janney | Buy |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2018-02-07 | 재확인 | Needham | Buy |
| 2017-12-05 | 재확인 | Needham | Buy |
| 2017-09-11 | 개시 | H.C. Wainwright | Buy |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-09-13 | 개시 | Gabelli & Co | Buy |
| 2015-06-01 | 개시 | Jefferies | Buy |
| 2015-06-01 | 개시 | Needham | Buy |
| 2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
Is It Too Late To Consider Collegium Pharmaceutical (COLL) After A 40% One Year Gain? - simplywall.st
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference - GlobeNewswire
Does Collegium’s 2026 Revenue Guidance After Insider Sales Change The Bull Case For COLL? - simplywall.st
Eastern Bank Buys 45,508 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 - AOL.com
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? - Yahoo Finance
Q4 Earnings Estimate for COLL Issued By HC Wainwright - Defense World
Best value stocks to buy for Dec. 18 - MSN
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Needham & Company LLC Forecasts Strong Price Appreciation for Collegium Pharmaceutical (NASDAQ:COLL) Stock - Defense World
Will Authorized Generic Nucynta Launch and New Credit Facility Change Collegium Pharmaceutical's (COLL) Narrative? - Yahoo Finance
(COLL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Can Collegium Pharmaceutical Inc. stock outperform in 2025 bull marketRisk Management & Accurate Trade Setup Notifications - Улправда
Will Collegium Pharmaceutical Inc. stock benefit from commodity pricesMarket Trend Report & AI Powered Buy/Sell Recommendations - Улправда
Is It Time To Reassess Collegium Pharmaceutical (COLL) After Its Strong Five Year Share Price Run? - Yahoo Finance
How Collegium Pharmaceutical Inc. stock performs in weak economyMarket Trend Review & Free Accurate Trade Setup Notifications - Улправда
Is Collegium Pharmaceutical Inc. stock positioned for digital transformationMarket Weekly Review & Long Hold Capital Preservation Plans - Улправда
A Look At Collegium Pharmaceutical (COLL) Valuation After 2026 Guidance And Nucynta Authorized Generic Agreements - simplywall.st
Collegium Pharmaceutical (NASDAQ:COLL) Trading Down 6.8% on Analyst Downgrade - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Price Target Cut to $56.00 by Analysts at Barclays - MarketBeat
How Good Is Collegium Pharmaceutical, Inc. (NASDAQ:COLL), When It Comes To ROE? - 富途牛牛
Collegium Pharmaceutical (NASDAQ:COLL) Price Target Raised to $56.00 - MarketBeat
Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $55 - 富途牛牛
COLL FinancialsIncome Statement - Quiver Quantitative
What 6 Analyst Ratings Have To Say About Collegium Pharmaceutical - Benzinga
Collegium Pharmaceutical (NASDAQ:COLL) Cut to “Hold” at Zacks Research - Defense World
Can Collegium Pharmaceutical Inc. stock sustain free cash flow growthJuly 2025 Retail & Daily Growth Stock Tips - Улправда
Collegium Provides 2026 Financial Guidance and Business Update - Sahm
How Collegium’s New $980 Million Credit Facility Could Reshape Collegium Pharmaceutical (COLL) Investors’ Risk Lens - Sahm
Collegium Pharmaceutical issues 2026 revenue guidance in line with estimates - MSN
Is Collegium Pharmaceutical Inc. stock trading at a premium valuationQuarterly Trade Summary & Consistent Return Strategy Ideas - Улправда
How Collegium Pharmaceutical Inc. (354) stock reacts to monetary easingJuly 2025 Setups & Advanced Technical Signal Analysis - Улправда
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Raises Target Price to $56 - 富途牛牛
Is Collegium Pharmaceutical Inc. (354) stock a top dividend aristocrat candidate2025 Big Picture & Consistent Growth Stock Picks - ulpravda.ru
Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spendingMarket Risk Report & Real-Time Chart Pattern Alerts - ulpravda.ru
How geopolitical tensions affect Collegium Pharmaceutical Inc. stockEarnings Miss & AI Optimized Trading Strategy Guides - ulpravda.ru
Collegium Pharmaceutical, Inc. Provides Earnings Guidance for Full Year 2026 - marketscreener.com
Collegium Pharmaceutical, Inc. Announces 2026 Financial Guidance - TradingView — Track All Markets
Star TribuneCollegium Provides 2026 Financial Guidance and Business Update - FinancialContent
Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Royalty Pharma (NASDAQ:RPRX) - TradingView — Track All Markets
Truist Securities Adjusts Price Target on Collegium Pharmaceutical to $55 From $48, Maintains Buy Rating - marketscreener.com
Is Collegium Pharmaceutical Inc a good long term investmentAutomated Trading Signals & Superior Growth Investment - earlytimes.in
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 5%Here's What Happened - MarketBeat
Collegium Announces the Closing of $980 Million Syndicated Credit Facility - The Globe and Mail
Liquidity Mapping Around (COLL) Price Events - Stock Traders Daily
Collegium Pharmaceutical Closes New $980 Million Credit Facility - TipRanks
Collegium Pharmaceutical Closes $980 Million Syndicated Credit Facility - marketscreener.com
Collegium Pharmaceutical Signs Credit Agreement With Truist Bank - TradingView — Track All Markets
Exchange Traded Concepts LLC Reduces Holdings in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Pacer Advisors Inc. Sells 87,066 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
2 Reasons to Avoid COLL and 1 Stock to Buy Instead - Barchart.com
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Collegium Pharmaceutical Inc 주식 (COLL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dreyer Scott | EVP & Chief Commercial Officer |
Dec 08 '25 |
Option Exercise |
15.90 |
17,600 |
279,840 |
121,213 |
| Dreyer Scott | EVP & Chief Commercial Officer |
Dec 08 '25 |
Sale |
48.17 |
17,600 |
847,855 |
103,613 |
| Balice-Gordon Rita J. | Director |
Dec 05 '25 |
Sale |
47.03 |
3,650 |
171,673 |
52,629 |
1.30%
1.45%
자본화:
|
볼륨(24시간):